Funder
Smoking Research Foundation
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Oncology
Reference19 articles.
1. The Editorial Board of the Cancer Statistics in Japan. CANCER STATISTICS IN JAPAN 2017. Foundation for Promotion of Cancer Research. https://www.fpcr.or.jp/.
2. Mottet N, Cornford P, van den Bergh RCN, Briers E (Patient Representative), De Santis M, Fanti S, et al. EAU guidelines: prostate cancer. uroweb.org/guideline/prostate-cancer/.
3. Kirby M, Hirst C, Crawford ED. Characterising the castration-resistant prostate cancer population: a systematic review. Int J Clin Pract. 2011;65:1180–92.
4. Scher HI, Fizazi K, Saad F, Taplin ME, Sternberg CN, Miller K, et al. Increased survival with enzalutamide in prostate cancer after chemotherapy. N Engl J Med. 2012;2012(367):1187–97.
5. Beer TM, Armstrong AJ, Rathkopf DE, Loriot Y, Sternberg CN, Higano CS, et al. Enzalutamide in metastatic prostate cancer before chemotherapy. N Engl J Med. 2014;371:424–33.